Radiation exposure after permanent prostate brachytherapy

Radiotherapy and Oncology

Volumn 79, Issue 1, 2006, Pages 65-69

  Cattani, Federica ^a   Vavassori, Andrea ^b   Polo, Alfredo ^b,c   Rondi, Elena ^a   Cambria, Raffaella ^a   Orecchia, Roberto ^b,d   Tosi, Giampiero ^a  

^a Division of Medical Physics   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

103Pd; 125I; Permanent prostate brachytherapy; Prostate cancer; Radiation safety

Indexed keywords

IODINE 125; PALLADIUM 103;

ACCREDITATION; ARTICLE; BRACHYTHERAPY; CALIBRATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; GLUTEUS MAXIMUS MUSCLE; HALF LIFE TIME; HEALTH SURVEY; HUMAN; IMPLANT; IONIZATION CHAMBER; ITALY; LAW; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; ONCOLOGY; POPULATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION ABSORPTION; RADIATION DETECTOR; RADIATION DOSE; RADIATION EXPOSURE; RELATIVE; SKIN SURFACE; UNIVERSITY HOSPITAL;

BRACHYTHERAPY; DRUG THERAPY, COMBINATION; ENVIRONMENTAL EXPOSURE; FAMILY; HUMANS; IODINE RADIOISOTOPES; ITALY; MALE; PALLADIUM; PATIENT EDUCATION; PROSTATIC NEOPLASMS; RADIATION MONITORING; RADIATION PROTECTION; RADIOISOTOPES; RETROSPECTIVE STUDIES;

EID: 33646474852     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.02.010     Document Type: Article

References (25)

1. Battermann J.J., Boon T.A., and Moerland M.A. Results of permanent prostate brachytherapy, 13 years of experience at a single institution. Radiother Oncol 71 (2004) 23-28
2. Dauer L.T., Zelefsky M.J., Horan C., Yamada Y., and St Germain J. Assessment of radiation safety instructions to patients based on measured dose rates following prostate brachytherapy. Brachytherapy 3 (2004) 1-6
3. Grimm P.D., Blasko J.C., Sylvester J.E., Meier R.M., and Cavanagh W. 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int J Radiat Oncol Biol Phys 51 (2001) 31-40
4. Horwitz E.M., Mitra R.K., Uzzo R.G., et al. Impact of target volume coverage with Rariation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants. Radiother Oncol 66 (2003) 173-179
5. Kollmeier M.A., Stock R., and Stone N. Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality. Int J Radiat Oncol Biol Phys 57 (2003) 645-653
6. Leclerc G., Lavallee M.C., Tubic D., Metivier J., Vigneault E., and Beaulieu L. Idealized line source configuration for permanent 125I prostate implants. Radiother Oncol 72 (2004) 213-220
7. Kuban D.A., Thames H.D., Levy L.B., et al. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 57 (2003) 915-928
8. Mangili P., Stea L., Cattani F., et al. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes. Radiother Oncol 71 (2004) 13-21
9. Matzkin H., Kaver I., Bramante-Schreiber L., et al. Comparison between two iodine-125 brachytherapy implant techniques: pre-planning and intra-operative by various dosimetry quality indicators. Radiother Oncol 68 (2003) 289-294
10. Michalski J., Mutic S., Eichling J., and Ahmed S.N. Radiation exposure to family and household members after prostate brachytherapy. Int J Radiat Oncol Biol Phys 56 (2003) 764-768
11. Nath R. New directions in radionuclide sources for brachytherapy. Semin Radiat Oncol 3 (1993) 278-289
12. Nath R., Anderson L.L., Luxton G., Weaver K.A., Williamson J.F., and Meigooni A.S. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM radiation therapy committee task group no. 43. Med Phys 22 (1995) 209-234
13. National Radiological Protection Board. Living with radiation, fifth ed. Chilton, Oxon, NRPB; 1998.
14. 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view. Radiother Oncol 78 (2006) 47-52
15. Nuclear Regulatory Commission. NUREG-1556. Consolidated guidance about material licenses, program-specific guidance about medical use licenses. Washington DC: US Nuclear Regulatory Commission, vol. 9; June 2002. p. U-1-U-27.
16. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
17. Polo A., Cattani F., Vavassori A., et al. MR and CT image fusion for postimplant analysis in permanent prostate seed implants. Int J Radiat Oncol Biol Phys 51 (2004) 31-40
18. Potters L., Klein E.A., Kattan M.W., et al. Monoterapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 71 (2004) 29-33
19. Smathers S., Wallner K., Korssjoen T., et al. Radiation safety parameters following prostate brachytherapy. Int J Radiat Oncol Biol Phys 45 (1999) 397-399
20. Van Gellekom M.P.R., Moerland M.A., Wijrdeman H.K., and Battermann J.J. Quality of permanent prostate implants using automated delivery with seedSelectron versus manual insertion of RAPID Strands™. Radiother Oncol 73 (2004) 49-56
21. Walsh P.C. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate. J Urol 163 (2000) 1802-1807
22. Williamson J.F., Coursey B.M., DeWerd L.A., Hanson W.F., and Nath R. Ibbott geoffrey-guidance to users of Nycomed Amersham and North American scientific, Inc., I-125 intestitial sources: dosimetry and calibration changes: recommenations of the american association of physicists in medicine radiation therapy committee ad hoc subcommittee on low-energy seed dosimetry. Med Phys 26 (1999) 570-573
23. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166 (2001) 876-881
24. Zelefsky M.J., Yamada Y., Cohen G., et al. Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique. Int J Radiat Oncol Biol Phys 48 (2000) 601-608
25. Zelefsky M.J., Yamada Y., Marion C., et al. Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys 55 (2003) 956-963